![](/images/general/no_picture/200_user.png)
Christopher D Rodee
Examiner (ID: 2399, Phone: (571)272-1388 , Office: P/1721 )
Most Active Art Unit | 1721 |
Art Unit(s) | 1737, 1507, 1753, 1506, 1721, 1795, 1796, 1754, 1756, 1715 |
Total Applications | 2448 |
Issued Applications | 1789 |
Pending Applications | 18 |
Abandoned Applications | 641 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18953582
[patent_doc_number] => 20240041909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => PREPARATION OF PRELIPOSOMAL ANNAMYCIN LYOPHILIZATE
[patent_app_type] => utility
[patent_app_number] => 18/481946
[patent_app_country] => US
[patent_app_date] => 2023-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18481946
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/481946 | Preparation of preliposomal annamycin lyophilizate | Oct 4, 2023 | Issued |
Array
(
[id] => 18842617
[patent_doc_number] => 20230405021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS
[patent_app_type] => utility
[patent_app_number] => 18/456719
[patent_app_country] => US
[patent_app_date] => 2023-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18456719
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/456719 | GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS | Aug 27, 2023 | Pending |
Array
(
[id] => 18962938
[patent_doc_number] => 11896677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Compositions and methods for delivery of RNA
[patent_app_type] => utility
[patent_app_number] => 18/357280
[patent_app_country] => US
[patent_app_date] => 2023-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 58
[patent_no_of_words] => 18542
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18357280
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/357280 | Compositions and methods for delivery of RNA | Jul 23, 2023 | Issued |
Array
(
[id] => 18931146
[patent_doc_number] => 11883542
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-01-30
[patent_title] => Chitosan film with ternary metal oxides
[patent_app_type] => utility
[patent_app_number] => 18/224327
[patent_app_country] => US
[patent_app_date] => 2023-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 5059
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18224327
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/224327 | Chitosan film with ternary metal oxides | Jul 19, 2023 | Issued |
Array
(
[id] => 19150183
[patent_doc_number] => 11975073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Lipid prodrugs of neurosteroids
[patent_app_type] => utility
[patent_app_number] => 18/341519
[patent_app_country] => US
[patent_app_date] => 2023-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92961
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18341519
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/341519 | Lipid prodrugs of neurosteroids | Jun 25, 2023 | Issued |
Array
(
[id] => 18915777
[patent_doc_number] => 11878043
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-01-23
[patent_title] => Method for synthesizing silver nanoparticles from
[patent_app_type] => utility
[patent_app_number] => 18/208435
[patent_app_country] => US
[patent_app_date] => 2023-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 2655
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18208435
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/208435 | Method for synthesizing silver nanoparticles from | Jun 11, 2023 | Issued |
Array
(
[id] => 18915762
[patent_doc_number] => 11878028
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-01-23
[patent_title] => Anti-tumor pharmaceutical composition comprising azvudine
[patent_app_type] => utility
[patent_app_number] => 18/199402
[patent_app_country] => US
[patent_app_date] => 2023-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 4731
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18199402
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/199402 | Anti-tumor pharmaceutical composition comprising azvudine | May 18, 2023 | Issued |
Array
(
[id] => 18656299
[patent_doc_number] => 20230302195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => HYDROGEL COMPOSITION FOR MUCOSAL LIFTING PROCEDURES WITHIN LUMENAL ANATOMICAL STRUCTURES
[patent_app_type] => utility
[patent_app_number] => 18/313099
[patent_app_country] => US
[patent_app_date] => 2023-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18313099
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/313099 | HYDROGEL COMPOSITION FOR MUCOSAL LIFTING PROCEDURES WITHIN LUMENAL ANATOMICAL STRUCTURES | May 4, 2023 | |
Array
(
[id] => 18565598
[patent_doc_number] => 20230255925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => BISMUTH-THIOL COMPOSITIONS AND METHODS FOR TREATING WOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/137521
[patent_app_country] => US
[patent_app_date] => 2023-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18137521
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/137521 | BISMUTH-THIOL COMPOSITIONS AND METHODS FOR TREATING WOUNDS | Apr 20, 2023 | Pending |
Array
(
[id] => 18746497
[patent_doc_number] => 11805781
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-07
[patent_title] => Eco-friendly control of red palm weevil using green synthesized silver nanoparticles of chlorophyll derivatives
[patent_app_type] => utility
[patent_app_number] => 18/134143
[patent_app_country] => US
[patent_app_date] => 2023-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 2885
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18134143
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/134143 | Eco-friendly control of red palm weevil using green synthesized silver nanoparticles of chlorophyll derivatives | Apr 12, 2023 | Issued |
Array
(
[id] => 18829558
[patent_doc_number] => 20230398082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => MRNA DELIVERY COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/194084
[patent_app_country] => US
[patent_app_date] => 2023-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18194084
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/194084 | MRNA delivery composition | Mar 30, 2023 | Issued |
Array
(
[id] => 18700039
[patent_doc_number] => 11786525
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-17
[patent_title] => High-efficiency anti-tumor nano-drug delivery system containing hydralazine and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 18/116817
[patent_app_country] => US
[patent_app_date] => 2023-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 4901
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18116817
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/116817 | High-efficiency anti-tumor nano-drug delivery system containing hydralazine and preparation method thereof | Mar 1, 2023 | Issued |
Array
(
[id] => 18497300
[patent_doc_number] => 20230219914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/174238
[patent_app_country] => US
[patent_app_date] => 2023-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18174238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/174238 | Process for preparing pitolisant hydrochloride and solid-state forms thereof | Feb 23, 2023 | Issued |
Array
(
[id] => 18389741
[patent_doc_number] => 20230157959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Lyophilized Compositions of Phenobarbital Sodium Salt
[patent_app_type] => utility
[patent_app_number] => 18/100804
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100804
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100804 | Lyophilized compositions of phenobarbital sodium salt | Jan 23, 2023 | Issued |
Array
(
[id] => 18297451
[patent_doc_number] => 20230107137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERY OF RNA
[patent_app_type] => utility
[patent_app_number] => 18/061725
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061725
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061725 | Compositions and methods for delivery of RNA | Dec 4, 2022 | Issued |
Array
(
[id] => 18700024
[patent_doc_number] => 11786510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseases
[patent_app_type] => utility
[patent_app_number] => 18/060503
[patent_app_country] => US
[patent_app_date] => 2022-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 18611
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18060503
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/060503 | Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseases | Nov 29, 2022 | Issued |
Array
(
[id] => 18443610
[patent_doc_number] => 11679163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Compositions and methods for delivery of RNA
[patent_app_type] => utility
[patent_app_number] => 18/057842
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 58
[patent_no_of_words] => 18548
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057842
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057842 | Compositions and methods for delivery of RNA | Nov 21, 2022 | Issued |
Array
(
[id] => 18270431
[patent_doc_number] => 20230091673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERY OF RNA
[patent_app_type] => utility
[patent_app_number] => 18/057833
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057833
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057833 | Compositions and methods for delivery of RNA | Nov 21, 2022 | Issued |
Array
(
[id] => 18240232
[patent_doc_number] => 20230072543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => HYDROGEL COMPOSITION FOR MUCOSAL LIFTING PROCEDURES WITHIN LUMENAL ANATOMICAL STRUCTURES
[patent_app_type] => utility
[patent_app_number] => 18/056109
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056109
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056109 | Hydrogel composition for mucosal lifting procedures within lumenal anatomical structures | Nov 15, 2022 | Issued |
Array
(
[id] => 18824425
[patent_doc_number] => 11839689
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Formulations of enzalutamide
[patent_app_type] => utility
[patent_app_number] => 17/985235
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 22438
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/985235 | Formulations of enzalutamide | Nov 10, 2022 | Issued |